| Website | synovexcorp.com |
| Employees |
| TOTAL | $3.5M |
| FUNDING TOTAL | $3.5M |
| Venture Round, 10/12 | $3.5M |
Synovex is developing a next generation, non-immunosuppressive treatment for fibrosis that occurs in fibrotic diseases and debilitating cartilage destruction in rheumatoid arthrits.